ABSTRACT
The genomes of two highly colistin-resistant strains of Pseudomonas aeruginosa (MICs ≥ 1,024 mg/mL) isolated from cystic fibrosis lung infections were sequenced and analyzed. Genes associated with colistin resistance (pmrAB, phoPQ) showed unique mutations compared to other strains with similar resistance levels.
KEYWORDS: colistin, Pseudomonas aeruginosa, antibiotic resistance, cystic fibrosis
ANNOUNCEMENT
Cystic fibrosis (CF) is a genetic disease marked by mucus build-up in airways with poor mucociliary clearance, creating an environment amenable to polymicrobial infections (1–3), from which Pseudomonas aeruginosa is frequently isolated (4). These P. aeruginosa infections are often treated with alternating courses of inhaled tobramycin or colistin (3, 5). We sequenced the genomes of two highly colistin-resistant strains of P. aeruginosa isolated from a bronchial wash specimen of a CF patient at the University of Pittsburgh Medical Center, collected under PRO12060302 as an exempt protocol approved by the University of Pittsburgh IRB, for use in a co-culture model to identify compounds with simultaneous antibiotic and adjuvant activities (6). Isolates were grown on TSA agar at 37°C for 24–48 h and identified by MicroScan Walkaway. Minimum inhibitory concentrations (MICs) for colistin were determined following CLSI standards for broth microdilution in Cation-adjusted Mueller-Hinton Broth (CAMHB, BD) (6, 7) (Table 1).
TABLE 1.
Draft genome assembly details and statistics of P. aeruginosa clinical isolates from the same bronchial wash specimena
| Strain | TRPA161 | TRPA162 |
|---|---|---|
| Species | P. aeruginosa | P. aeruginosa |
| Colistin MIC (µg/mL) | 8,192 | 1,024 |
| Genome size (bp) | 7,050,894 | 6,958,250 |
| Total read coverage | 400× | 400× |
| Effective read length | 2 × 150 | 2 × 150 |
| No. of reads | 3,894,656 | 3,710,459 |
| % Bases ≥30 | 91.41 | 90.28 |
| # of contigs | 63 | 51 |
| GC content (%) | 60.76 | 61.66 |
| N50 value (bp) | 171,702 | 205,044 |
| Mutations in PmrA | None | None |
| Mutations in PmrB | Y 345 H | Y 345 H |
| Mutations in PhoP | None | None |
| Mutations in PhoQ |
|
|
| Genome accession no. | JBLYTN000000000 | JBLYTM000000000 |
“*” indicates stop codon and protein termination.
For whole-genome sequencing, strains were grown in CAMHB at 37°C for 18 h, pelleted, and stored at −80°C. DNA extraction and genome sequencing were conducted by Azenta Genewiz. DNA was extracted using the PureLink Genomic DNA Kit, fragmented by acoustic shearing, and prepared for libraries using NEBNext Ultra DNA Library Prep Kit for Illumina, following manufacturer recommendations. Libraries were sequenced on an Illumina MiSeq platform with a 2 × 150 paired-end sequencing configuration. Default parameters were used for all software unless otherwise specified. The paired-end samples were quality assessed via FastQC v0.11.5 (8). Raw data were quality trimmed using Trimmomatic v0.36 (9) with palindrome mode enabled, then down-sampled to 20 million reads. SPAdes v3.10 (10) de novo genome assembler was used on each sample. The assembled contigs were filtered for 500 bp. Quast v4.2 (11) was used to generate statistics for the assemblies. Genome annotation was completed using NCBI Prokaryotic Genome Annotation Pipeline v6.10 (12–14).
Colistin-resistance-associated genes pmrAB and phoPQ were analyzed using Geneious Prime 2025.0.2. These two-component systems are associated with the modification of lipid A, leading to colistin resistance in Gram-negative pathogens (15–20). Comparison to the P. aeruginosa PAO1 reference genome (NC_002516) showed significant mutations and predicted amino acid changes (Table 1). Notably, the last approximately 70 nucleotides of phoQ shared under 50% similarity to PAO1, predicting a truncated PhoQ protein. Mutations did not match other P. aeruginosa strains with similarly high colistin resistance (6, 20, 21), prompting further research into the mechanism by which these mutations contribute to colistin resistance.
ACKNOWLEDGMENTS
This study was funded by NIH grant AI104895 to C.M. and Y.D. and the University of Notre Dame.
Contributor Information
Anne E. Mattingly, Email: amyyv@missouri.edu.
David Rasko, University of Maryland School of Medicine, Baltimore, Maryland, USA.
DATA AVAILABILITY
Whole-genome shotgun sequencing project and SRA of TRPA161 (JBLYTN000000000) and TRPA162 (JBLYTM000000000) are deposited in NCBI GenBank as Bioproject PRJNA1194588. The first versions are described in this paper. Sequences for genes specific to colistin-resistance mechanisms (pmrAB, phoPQ) are deposited in NCBI GenBank as PQ720584, PQ720585, PQ720586, and PQ720587 (TRPA161) and PQ720590, PQ720591, PQ720592, and PQ720593 (TRPA162).
REFERENCES
- 1. Allen L, Allen L, Carr SB, Davies G, Downey D, Egan M, Forton JT, Gray R, Haworth C, Horsley A, Smyth AR, Southern KW, Davies JC. 2023. Future therapies for cystic fibrosis. Nat Commun 14:693. doi: 10.1038/s41467-023-36244-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Bernardy EE, Raghuram V, Goldberg JB. 2022. Staphylococcus aureus and Pseudomonas aeruginosa isolates from the same cystic fibrosis respiratory sample coexist in coculture. Microbiol Spectr. doi: 10.1128/spectrum.00976-22:e0097622 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Foundation CF . 2021. Antibiotics, on Cystic Fibrosis Foundation. Available from: https://www.cff.org/managing-cf/antibiotics
- 4. Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, Ashare A, Elborn JS, De Soyza A, Carroll MP, Hoffman LR, Lanyon C, Moskowitz SM, O’Toole GA, Parkhill J, Planet PJ, Teneback CC, Tunney MM, Zuckerman JB, Bruce KD, van der Gast CJ. 2020. Lung function and microbiota diversity in cystic fibrosis. Microbiome 8:45. doi: 10.1186/s40168-020-00810-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Manos J. 2021. Current and emerging therapies to combat cystic fibrosis lung infections. Microorganisms 9:1874. doi: 10.3390/microorganisms9091874 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Mattingly AE, Li H, Melander RJ, Melander C. 2025. Validation of a cystic fibrosis co-culture model for the identification of dual acting compounds with antibiotic and antibiotic adjuvant properties. ACS Infect Dis 11:1686–1696. doi: 10.1021/acsinfecdis.5c00226 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. CLSI . 2021. Performance Standards for Antimicrobial Susceptibility Testing. 31st edition. Clinical and Laboratory Standards Institute. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Wingett SW, Andrews S. 2018. FastQ Screen: A tool for multi-genome mapping and quality control. F1000Res 7:1338. doi: 10.12688/f1000research.15931.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. doi: 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072–1075. doi: 10.1093/bioinformatics/btt086 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Li W, O’Neill KR, Haft DH, DiCuccio M, Chetvernin V, Badretdin A, Coulouris G, Chitsaz F, Derbyshire MK, Durkin AS, Gonzales NR, Gwadz M, Lanczycki CJ, Song JS, Thanki N, Wang J, Yamashita RA, Yang M, Zheng C, Marchler-Bauer A, Thibaud-Nissen F. 2021. RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation. Nucleic Acids Res 49:D1020–D1028. doi: 10.1093/nar/gkaa1105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Haft DH, DiCuccio M, Badretdin A, Brover V, Chetvernin V, O’Neill K, Li W, Chitsaz F, Derbyshire MK, Gonzales NR, Gwadz M, Lu F, Marchler GH, Song JS, Thanki N, Yamashita RA, Zheng C, Thibaud-Nissen F, Geer LY, Marchler-Bauer A, Pruitt KD. 2018. RefSeq: an update on prokaryotic genome annotation and curation. Nucleic Acids Res 46:D851–D860. doi: 10.1093/nar/gkx1068 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP, Zaslavsky L, Lomsadze A, Pruitt KD, Borodovsky M, Ostell J. 2016. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res 44:6614–6624. doi: 10.1093/nar/gkw569 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Moskowitz SM, Ernst RK, Miller SI. 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol 186:575–579. doi: 10.1128/JB.186.2.575-579.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock REW. 2011. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A . Antimicrob Agents Chemother 55:3743–3751. doi: 10.1128/AAC.00256-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Yamada N, Kamoshida G, Shiraishi T, Yamaguchi D, Matsuoka M, Yamauchi R, Kanda N, Kamioka R, Takemoto N, Morita Y, Fujimuro M, Yokota S-I, Yahiro K. 2024. PmrAB, the two-component system of Acinetobacter baumannii, controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions. J Bacteriol 206:e0043523. doi: 10.1128/jb.00435-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Gunn JS, Miller SI. 1996. PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 178:6857–6864. doi: 10.1128/jb.178.23.6857-6864.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Macfarlane EL, Kwasnicka A, Ochs MM, Hancock RE. 1999. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol Microbiol 34:305–316. doi: 10.1046/j.1365-2958.1999.01600.x [DOI] [PubMed] [Google Scholar]
- 20. Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, Høiby N, Moskowitz SM. 2011. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother 55:5761–5769. doi: 10.1128/AAC.05391-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Moskowitz SM, Brannon MK, Dasgupta N, Pier M, Sgambati N, Miller AK, Selgrade SE, Miller SI, Denton M, Conway SP, Johansen HK, Høiby N. 2012. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother 56:1019–1030. doi: 10.1128/AAC.05829-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Whole-genome shotgun sequencing project and SRA of TRPA161 (JBLYTN000000000) and TRPA162 (JBLYTM000000000) are deposited in NCBI GenBank as Bioproject PRJNA1194588. The first versions are described in this paper. Sequences for genes specific to colistin-resistance mechanisms (pmrAB, phoPQ) are deposited in NCBI GenBank as PQ720584, PQ720585, PQ720586, and PQ720587 (TRPA161) and PQ720590, PQ720591, PQ720592, and PQ720593 (TRPA162).
